Phase I study of H3B-6545 in patients (pts) with estrogen receptor-positive (ER plus ) breast cancer

被引：0
|
作者：
Ono, M. [1 ]
Kogawa, T. [1 ]
Kitano, S. [1 ]
Shimoi, T. [2 ]
Yamamoto, K. [2 ]
Kobayashi, S. [3 ]
Ichikawa, Y. [3 ]
Yamaguchi, K. [4 ]
Otake, Y. [3 ]
Hojo, S. [5 ]
Yonemori, K. [2 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Adv Med Dev Ctr, Tokyo, Japan
[2] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan
[3] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Japan & Asia Clin Dev,Dept Oncol, Tokyo, Japan
[4] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Clin Pharmacol Sci Dept, Tokyo, Japan
[5] Eisai & Co Ltd, DHBL, Clin Evidence Generat Fulfillment, Clin Data Sci Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55O
引用
收藏
页码：S1487 / S1487
页数：1
相关论文
共 50 条
  • [31] Hyperthermia plus radiotherapy in Estrogen receptor positive (ER plus ) breast cancer; before or after?
    Joveini, Zahra
    Behrouzkia, Zhaleh
    Aghdam, Reza Zohdi
    CANCER RESEARCH, 2017, 77 (22)
  • [32] Phase I study of PI3Kα inhibitor BYL719+aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Shah, Payal D.
    Moynahan, Mary E.
    Modi, Shanu
    Hamilton, Nicola
    Caravella, Betty Ann
    Zamora, Stephen
    Dang, Chau
    Gilewski, Theresa
    Traina, Tiffany
    Comen, Elizabeth
    Sugarman, Steven M.
    D'Andrea, Gabriella
    Lake, Diana
    Goldfarb, Shari
    Patil, Sujata
    Covey, Anne
    Berger, Michael
    Lacouture, Mario
    Norton, Larry
    Hudis, Clifford A.
    BaseIga, Jose
    Chandarlapaty, Sarat
    Dickler, Maura
    CANCER RESEARCH, 2015, 75
  • [33] H3B-6545, a selective estrogen receptor covalent antagonist, prevents bone loss in ovariectomized Sprague-Dawley rats
    Kim, Amy H.
    Korpal, Manav
    Hukkanen, Renee
    Rioux, Nathalie
    Warmuth, Markus
    Smith, Peter
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [34] RACIAL/ETHNIC DIFFERENCES IN USE OF ADJUVANT HORMONAL THERAPY AMONG WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER
    Livaudais, J.
    Li, C.
    John, E.
    Daly, M.
    Terry, M.
    Buys, S.
    Thompson, B.
    LaCroix, A.
    Habel, L.
    Coronado, G.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S23 - S23
  • [35] Estrogen receptor-positive (ER plus ) metastatic breast cancer (MBC) patients (pts) with extreme responses (ERs) to capecitabine having tumors with genomic alterations in DNA repair and chromatin remodeling genes
    Levin, Maren K.
    Wang, Kai
    Yelensky, Roman
    Cao, Ying
    Ramos, Corinne
    Hoke, Glenn D.
    Pippen, John E.
    Blum, Joanne Lorraine
    Brooks, Barry Don
    Palmer, Gary A.
    Palma, Norma Alonzo
    Balasubramanian, Sohail
    Ross, Jeffrey S.
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
    Didembourg, Marie
    Reda, Sara
    Oldenburg, Johannes
    Ruehl, Heiko
    Douxfils, Jonathan
    Morimont, Laure
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 546 - 554
  • [37] VALIDATION OF PRO_10, A MULTIGENE PROGNOSTIC SIGNATURE, IN PATIENTS (PTS) WITH EARLY, ESTROGEN RECEPTOR POSITIVE (ER plus ) POSTMENOPAUSAL BREAST CANCER (BC)
    Moor, A. E.
    Guevara, C.
    Altermatt, H. J.
    Jaggi, R.
    Aebi, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 80 - 80
  • [38] B-Cell-Mediated Immunity Predicts Survival of Patients With Estrogen Receptor-Positive Breast Cancer
    Lee, Seungbok
    Kang, Byung-Hee
    Lee, Han-Byoel
    Jang, Bum-Sup
    Han, Wonshik
    Kim, In Ah
    JCO PRECISION ONCOLOGY, 2024, 8
  • [39] A phase I study of the AKT inhibitor MK-2206 plus hormonal therapy in postmenopausal women with estrogen receptor positive (ER plus ) metastatic breast cancer (MBC)
    Ma, Cynthia X.
    Gao, Feng
    Naughton, Michael
    Pluard, Timothy J.
    Sorscher, Steven
    Creekmore, Allison N.
    Guo, Zhanfang
    Dehdashti, Farrokh
    Park, Ben Ho
    Lockhart, Albert C.
    Doyle, L. Austin
    Ellis, Matthew J.
    Erlanger, Bracha
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial
    Loi, Sherene
    Salgado, Roberto
    Curigliano, Giuseppe
    Romero Diaz, Roberto Ivan
    Delaloge, Suzette
    Rojas Garcia, Carlos Ignacio
    Kok, Marleen
    Saura, Cristina
    Harbeck, Nadia
    Mittendorf, Elizabeth A.
    Yardley, Denise A.
    Suarez Zaizar, Alberto
    Caminos, Facundo Rufino
    Ungureanu, Andrei
    Reinoso-Toledo, Joaquin G.
    Guarneri, Valentina
    Egle, Daniel
    Ades, Felipe
    Pacius, Misena
    Chhibber, Aparna
    Chandra, Rajalakshmi
    Nathani, Raheel
    Spires, Thomas
    Wu, Jenny Qun
    Pusztai, Lajos
    Mcarthur, Heather
    NATURE MEDICINE, 2025, 31 (02) : 433 - 441
12345